Abstract
The MPTP-animal model of Parkinson’s disease has significantly advanced our understanding of Parkinson’s disease and the dopaminergic system, helping to establish disease mechanisms and develop therapeutic targets. The non-human primate (NHP) MPTP model is particularly valuable for replicating core Parkinson’s disease motor symptoms, anatomical changes and electrophysiological variations seen in humans. However, MPTP-injection protocols often cause substantial suffering, leading to euthanasia. While some post-MPTP primates recovered spontaneously, purposefully induced recovery was considered unattainable. Our team developed a novel intensive care protocol (NICP) promoting complete recovery from MPTP-induced severe parkinsonism in NHPs. NICP provides therapeutic, nutritional and social support, enabling behavioral recovery and subsequent retirement to a primate sanctuary. This innovation enhances animal welfare and opens new prospects for veterinary care, emphasizing the need to explore recovery mechanisms for other chronic conditions induced for research.
| Original language | English |
|---|---|
| Pages (from-to) | 523-529 |
| Number of pages | 7 |
| Journal | Laboratory Animals |
| Volume | 59 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2025
Keywords
- Alternatives
- animal use
- disease model
- ethics and welfare
- organisms and models
- primate
- refinement